Gout | Gout CME Learning Center

Gout
CME Learning Center

CME Activities

A Patient-Centered Approach to Successful Management of Chronic Gout CME/CE Drs Wortmann and Edwards and nurse practitioner Debra Lloyd provide expert guidance on the treatment of acute and chronic gout. DISCUSS this topic with Dr Wortmann who will address your questions/comments on Medscape Discuss. JOIN the discussion now!
Medscape Education Rheumatology, February 2012
Footwear Associated With Foot Disability in Patients With Gout CME A study shows that patients with chronic gout often wear shoes that demonstrate excessive wear patterns, which is associated with a higher risk for foot disability and impaired function.
Medscape Education Clinical Briefs, October 2011
Six-Month Treatment of Refractory Gout Improves Outcomes CME Two randomized studies show that 6-month treatment of refractory gout reduced uric acid levels and improved other outcomes.
Medscape Education Clinical Briefs, August 2011
Diagnosis and Treatment of Gout Reviewed The main aim of therapy for acute gout is rapid relief of pain and disability caused by intense inflammation, using nonsteroidal anti-inflammatory drugs, colchicine, glucocorticoids, and corticotropin.
Medscape Education Clinical Briefs, February 2011
Gout and Hyperuricemia: Management in Clinical Practice Robert T. Keenan, MD, MPH, reviews an evidence-based approach to hyperuricemia and gout, focusing on hard-to-treat gout.
Medscape Education Rheumatology, December 2010
Hyperuricemia and Gout: Understanding the Drivers of Quality of Care Robert Wortmann, MD, and Debra C. Lloyd, APRN, MS, highlight quality care for patients with hyperuricemia and gout, from diagnosis, to management strategies, to patient education.
Medscape Education Rheumatology, November 2010
Education in the Round: Reflections on EULAR 2010 Review the latest information from EULAR 2010 related to the treatment of rheumatoid arthritis, osteoporosis, gout, and the seronegative spondyloarthropathies.
November 2010
FDA Approves Pegloticase for Refractory Gout The FDA has approved pegloticase as the first and only treatment for chronic gout in adults refractory to conventional therapy.
Medscape Education Clinical Briefs, September 2010
A 72-Year-Old Man With Multiple Medical Problems: Should His Regimen Be Simplified? CME Polypharmacy can lead to a higher rate of drug interactions and clinical adverse events, particularly among older adults. What is the best means to reduce polypharmacy?
Medscape Education Family Medicine, August 2010
Rule Developed to Diagnose Gout Using Clinical Variables A rule for diagnosing gout uses 7 easily identifiable clinical variables and helps eliminate the need for joint fluid aspiration in some patients.
Medscape Education Clinical Briefs, July 2010
FDA Approves New Dosing Guidelines for Colchicine Taken With Protease Inhibitors The FDA has issued new dosing guidelines for colchicine when used with protease inhibitors in HIV patients.
Medscape Education Clinical Briefs, May 2010
Gout: Achieving Effective Communication Between Clinician and Patient to Improve Outcome Robert A. Terkeltaub, MD, reviews effective patient communication skills to encourage early presentation, routine monitoring, and secondary prevention of gout and flares.
Medscape Education Rheumatology, May 2010
Higher Risk of AMI in Women With Gout A link between gout and AMI has been previously documented in men: now a new cohort study suggests gout may be even more important as a comorbidity in women.
Heartwire CME, February 2010
Clinical Presentation and Diagnosis of Calcium Deposition Diseases Calcium deposition diseases can present in similar ways to other arthropathies and investigations are needed to distinguish them from conditions such as pseudogout, gout, and septic arthritis.
International Journal of Clinical Rheumatology, January 2010
Update on Gout: New Therapeutic Strategies and Options What are the most recent treatment strategies for gout?
Nature Reviews Rheumatology, December 2009
Fast Facts in Gout Review the "must-know" issues for the diagnosis and long-term clinical management of gout.
September 2009
Clinical Guide to Managing Advanced Gouty Arthritis and Associated Complications Understand the complications of gout and the effectiveness of newer uric acid–lowering therapies.
August 2009
Complexities of Gout: Comorbidities Cause or Effect? Review the epidemiology of gout and consider its comorbidities, which may exacerbate flares of gout.
August 2009
FAQs in the Modern Management of Gout Learn the "must-know" issues facing healthcare professionals in the diagnosis and treatment of gout.
July 2009
Managing Gout -- From Acute Relief to Long-term Control CME/CE Learn about the presenting symptoms of gout and the treatment options available for lowering serum urate to appropriate levels.
May 2009

Latest Clinical Briefs in Gout

Footwear Associated With Foot Disability in Patients With Gout CME
October 2011
Six-Month Treatment of Refractory Gout Improves Outcomes CME
August 2011
Diagnosis and Treatment of Gout Reviewed
February 2011
FDA Approves Pegloticase for Refractory Gout
September 2010
Rule Developed to Diagnose Gout Using Clinical Variables
July 2010

Gout is defined as an arthritis associated with the presence of MSU crystals in synovial fluid or tissue. Gout is often classified as primary or secondary and both forms are associated with hyperuricemia. Gout associated with an inborn error in metabolism or decreased renal excretion without other renal disease is referred to as primary gout, whereas gout associated with an acquired disease or the use of a drug is called secondary gout. In both primary and secondary gout, chronic hyperuricemia may be the result of overproduction of uric acid caused by increased purine intake, synthesis, or breakdown, or it may be the result of decreased renal excretion of urate.

GoutCME Learning Center

CME Activities

Latest Clinical Briefs in Gout

About Gout

Gout
CME Learning Center